BioSpace News Archive

Report From Orexo’s Annual General Meeting, 15 April 2016

April 18, 2016
·
4 min read
Business

Tauriga Sciences Inc. Appoints Mr. Keith M. Berman As A Member Of The Company’s Board Of Directors

April 18, 2016
·
3 min read
Business

Freeline Therapeutics Acquires Munich-Based Manufacturing Technology Platform And Has Appointed Dr Markus Hörer As Chief Technology Officer

April 18, 2016
·
3 min read
Business

Joseph Horrigan Joins AMO Pharma As Chief Medical Officer

April 18, 2016
·
3 min read
Drug Development

Merus To Present Interim Clinical Data From Ongoing Phase I/II Clinical Trial Of Its Lead Bispecific Antibody Candidate, MCLA-128, At The AACR 2016 Annual Meeting

April 18, 2016
·
4 min read
Deals

Recipharm AB Creates A Global CDMO Leader Through SEK 1.7 Billion Strategic Acquisitions In The US, Sweden And India

April 18, 2016
·
17 min read
Drug Development

RedHill Biopharma Announces Positive FDA Meeting On RHB-105 Path To Approval And Planned Confirmatory Phase III Study For H. Pylori Infection

April 18, 2016
·
7 min read
Business

Enterome In-Licenses Novel Compounds From Vertex To Treat Microbiome-Related Inflammatory Bowel Diseases

April 18, 2016
·
2 min read
Policy

Arbutus’ LNP Licensee Alnylam Receives Accelerated Assessment of Patisiran from European Medicines Agency (EMA)

Accelerated assessment may provide a reduced review timeline from 210 to 150 days once the marketing authorization application (MAA) is filed and validated, which Alnylam intends to file by year-end 2017.

April 18, 2016
·
3 min read
Technical University Of Munich Release: Mechanics Of The Cell

April 18, 2016
·
4 min read